Newsletter Subject

Video of ACOG Presenter Being Slapped Goes Viral

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Jun 3, 2023 11:18 AM

Email Preheader Text

Weekly Review Saturday, June 03, 2023 THE BREAK ROOM CME SPOTLIGHT THE BREAK ROOM ADVERTISEMENT CME

[MEDPAGE TODAY]( Weekly Review Saturday, June 03, 2023 [Video of ACOG Presenter Being Slapped Goes Viral]( [Is Berberine Really 'Nature's Ozempic'?]( [Fired COVID Whistleblower Doesn't Want to Settle His Case]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Leveraging Expert-Informed Adverse Event Management and Supportive Care Strategies to Improve Patient Outcomes in Bladder Cancer]( [Are Health Outcomes Any Different With MDs vs DOs?]( [Overuse of Some Disinfectants Can Do More Harm Than Good]( THE BREAK ROOM [Play Today's Wordosis: Our Medical Word Game]( ADVERTISEMENT [Want to Solve the Nurse Shortage?]( CME SPOTLIGHT [Integrating Novel Classes of Immunotherapy Into Treatment Paradigms in Advanced/Metastatic Melanoma]( [Why Are Female Doctors Sued Nearly Half as Often as Male Doctors?]( [Nurse Accused of Killing Patients With Insulin; Naturopath Settles False Claims Suit]( [Catching the Optimal Amount of Z's May Be Protective Against Long COVID]( CME SPOTLIGHT [Utilizing Evidence-Based and Guideline-Informed Approaches to Improve TNBC Care]( [PET Scan for Alzheimer's Dx; Predicting Colon Cancer Survival]( [Long COVID Cognitive, Depressive Symptoms Tied to Brain Inflammation Marker]( [Best Exercise Time; FDA's Diabetes Guidance; Weight Discrimination Illegal in N.Y.C.]( CME SPOTLIGHT [Immunotherapy in Advanced Melanoma: Evidence-Based Adverse Event Management Strategies to Improve Patient Outcomes]( [Doc Accused of 'Fertility Fraud' Dies After Handmade Plane Crashes]( ['Succession Syndrome'; Opioid Use Disorder LAI Approved; Seizures of Ketamine Rising]( [What's With the Buzz Around NAD+ Injections?]( CME SPOTLIGHT [Integrating the Latest Evidence into Patient-Centered Treatment for Advanced/Metastatic Triple Negative Breast Cancer]( [FDA Warns on Certain Forms of Compounded Semaglutide]( [Treating Early Hospitalization Blood Pressure Deemed a No-No for Patient Safety]( [Abortion Bans Are Putting Basic Healthcare at Risk]( CME SPOTLIGHT [Incorporating Recent Data Into Current Treatment Paradigms in Melanoma]( [NT-proBNP for All; Risky Weekend HF Admits; Ticagrelor for Infective Endocarditis?]( [Sotagliflozin Gets FDA's Blessing for Heart Failure]( [UnitedHealthcare in the Hot Seat Over GI Procedure 'Advance Notification' Policy]( CME SPOTLIGHT [Evidence-Based Strategies to Improve Outcomes for Patients With Gastroesophageal Cancers]( [Bed Bug Anaphylaxis; Heart Block Relationships; What's It Like to Date a Nurse?]( [Benefits Found for Hand OA Drug Treatments]( [Trial Shows RA Can Be Stopped at Preclinical Stage]( CME SPOTLIGHT [Clinical Case Challenge: Applying the Latest Evidence to Improve Outcomes in BRAF Mutant Advanced Melanoma]( [Second RSV Vaccine Lands Approval for Older Adults]( [CDC: Children's Brain Infections Rose Last Winter, But Remained Rare]( ['If the Narcan Isn't Working, Give More' and Other Myths About Naloxone Use]( [Just Say No: Unlocking the Secret to More Time and Energy]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2023-06-03&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

26/06/2024

Sent On

26/06/2024

Sent On

26/06/2024

Sent On

25/06/2024

Sent On

25/06/2024

Sent On

24/06/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.